LIVE Millions of Americans need drugs like Ozempic. Will it bankrupt the healthcare system?

Providing GLP-1 drugs to 19.7 million Medicare beneficiaries with obesity would cost $268 billion a year, researchers estimate in a recent study. Correspondents of «The Karelia Business» closely monitor the latest events around the world to provide you with the freshest and most up-to-date information. Don't miss the chance to stay informed about all the latest developments — subscribe to our news feed now!